Screening behavior in women at increased familial risk for breast cancer

被引:31
作者
Antill, Yoland C.
Reynolds, John
Young, Mary Anne
Kirk, Judy A.
Tucker, Katherine M.
Bogtstra, Tarli L.
Wong, Shirley S.
Dudding, Tracy E.
Di Iulio, Juliana L.
Phillips, Kelly-Anne
机构
[1] Peter MacCallum Canc Ctr, Dept Hematol & Med Oncol, Melbourne, Vic 8006, Australia
[2] Peter MacCallum Canc Ctr, Ctr Stat, Melbourne, Vic 8006, Australia
[3] Univ Melbourne, Melbourne, Vic, Australia
[4] Westmead Hosp, Westmead, NSW 2145, Australia
[5] Prince Wales Hosp, Randwick, NSW 2031, Australia
[6] Monash Med Ctr, Clayton, Vic 3168, Australia
[7] Royal Melbourne Hosp, Parkville, Vic 3050, Australia
[8] Hunter Genet, Newcastle, NSW, Australia
关键词
BRCA1; BRCA2; breast neoplasm; ovarian neoplasm; screening;
D O I
10.1007/s10689-006-0006-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
This multicenter study examined the adherence of high-risk women to screening recommendations for breast and ovarian cancer following consultation at a familial cancer clinic (FCC). Self-report questionnaires assessing recall of screening advice, tests undertaken, risk perception, anxiety (Impact of Events Scale) and demographics were mailed to 396 consecutive eligible women who had attended one of six FCCs a median of 3.6 years prior. Family history, genetic test results and screening recommendations were abstracted from medical records. 182/266 (68.4%) women responded with 130 lost to follow-up. The proportions of women undertaking at least the recommended frequency of screening tests were: breast-self examination (BSE) 50.4%, clinical breast examination (CBE) 66.0%, mammography 82.2%, transvaginal ultrasound (TVUS) 70.0%, CA125 84.0%. Factors associated with adherence to screening were: higher anxiety for BSE and CBE, being BRCA1/2 positive for CBE, older age, method of arrangement and having at least one affected first degree relative for mammography. Factors significantly associated with over-adherence were higher scores for anxiety for BSE and CBE and younger age (< 40 years) for TVUS. Between 41.3% (BSE) and 57.6% (CBE) of women incorrectly recalled their screening recommendations. A substantial minority of high-risk women do not adhere to screening advice. Strategies to improve the accuracy of recall of recommendations and the uptake of recommended screening are required.
引用
收藏
页码:359 / 368
页数:10
相关论文
共 46 条
[1]  
*ACNATNBCCITOC, 2004, CLIN PRACT GUID MAN
[2]  
Antill YC, 2005, CANCER FORUM, V29, P106
[3]  
ANTILL YP, 2004, GYNECOLOGIC CANC CON, P341
[4]   Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history:: A combined analysis of 22 studies [J].
Antoniou, A ;
Pharoah, PDP ;
Narod, S ;
Risch, HA ;
Eyfjord, JE ;
Hopper, JL ;
Loman, N ;
Olsson, H ;
Johannsson, O ;
Borg, Å ;
Pasini, B ;
Radice, P ;
Manoukian, S ;
Eccles, DM ;
Tang, N ;
Olah, E ;
Anton-Culver, H ;
Warner, E ;
Lubinski, J ;
Gronwald, J ;
Gorski, B ;
Tulinius, H ;
Thorlacius, S ;
Eerola, H ;
Nevanlinna, H ;
Syrjäkoski, K ;
Kallioniemi, OP ;
Thompson, D ;
Evans, C ;
Peto, J ;
Lalloo, F ;
Evans, DG ;
Easton, DF .
AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 72 (05) :1117-1130
[5]   Genetic testing for a BRCA1 mutation:: Prophylactic surgery and screening behavior in women 2 years post testing [J].
Botkin, JR ;
Smith, KR ;
Croyle, RT ;
Baty, BJ ;
Wylie, JE ;
Dutson, D ;
Chan, A ;
Hamann, HA ;
Lerman, C ;
McDonald, J ;
Venne, V ;
Ward, JH ;
Lyon, E .
AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2003, 118A (03) :201-209
[6]   Effectiveness of breast cancer surveillance in BRCA1/2 gene mutation carriers and women with high familial risk [J].
Brekelmans, CTM ;
Seynaeve, C ;
Bartels, CCM ;
Tilanus-Linthorst, MMA ;
Meijers-Heijboer, EJ ;
Crepin, CMG ;
van Geel, AN ;
Menke, M ;
Verhoog, LC ;
van den Ouweland, A ;
Obdeijn, IM ;
Klijn, JGM .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (04) :924-930
[7]   Recommendations for follow-up care of individuals with an inherited predisposition to cancer .2. BRCA1 and BRCA2 [J].
Burke, W ;
Daly, M ;
Garber, J ;
Botkin, J ;
Kahn, MJE ;
Lynch, P ;
McTierman, A ;
Offit, K ;
Perlman, J ;
Petersen, G ;
Thomson, E ;
Varricchio, C .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (12) :997-1003
[8]  
Caplan LS, 2003, CANCER EPIDEM BIOMAR, V12, P1182
[9]  
Consedine NS, 2004, CANCER EPIDEM BIOMAR, V13, P501
[10]  
*CYT SOFTW CORP, 2001, STATXACT